Atlas Trials

Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients

Clinical trial NCT01769768 · COMPLETED

Trial details

NCT number
NCT01769768
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2013-04-01
Primary completion
2016-08-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.